Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia

Leukemia. 2020 Nov;34(11):2898-2902. doi: 10.1038/s41375-020-0895-9. Epub 2020 Jun 2.

Priscilla Wander^{1

2}, Laurence C Cheung^{3

4}, Sandra S Pinhanҫos^{1

5}, Luke Jones¹, Mark Kerstjens², Susan T C J M Arentsen-Peters¹, Sajla Singh³, Grace-Alyssa Chua³, Patricia Garrido Castro¹, Pauline Schneider¹, M Emmy M Dolman¹, Bianca Koopmans¹, Jan J Molenaar¹, Rob Pieters¹, C Michel Zwaan^{1

2}, Rishi S Kotecha^#^{6

7

8}, Ronald W Stam^#⁹

¹ Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
² Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
³ Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
⁴ School of Pharmacy and Biomedical Sciences, Curtin University, Perth, WA, Australia.
⁵ CNC-Center for Neurosciences and Cell Biology, University of Coimbra, Coimbra, Portugal.
⁶ Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.
⁷ School of Pharmacy and Biomedical Sciences, Curtin University, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.
⁸ Department of Haematology and Oncology, Perth Children's Hospital, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.
⁹ Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. R.W.Stam@prinsesmaximacentrum.nl.

^# Contributed equally.

No abstract available

Publication types